Volume 21, Number 10—October 2015
Synopsis
Characteristics and Factors Associated with Death among Patients Hospitalized for Severe Fever with Thrombocytopenia Syndrome, South Korea, 2013
Jaeseung Shin, Donghyok Kwon, Seung-Ki Youn, and Ji-Hyuk Park
Table 2
Clinical characteristics of hospitalized case-patients with confirmed severe fever with thrombocytopenia syndrome, by outcome, South Korea, 2013*
| Characteristics | No. (%) case-patients |
p value† | ||
|---|---|---|---|---|
| Total, n = 35 | Died, n = 16 | Recovered, n = 19 | ||
| Fever/chills |
35 (100) |
16 (100) |
19 (100) |
1.000 |
| Fever, n = 32 | ||||
| ≤39.0°C | 25 (78) | 9 (64) | 16 (89) | 0.195 |
| >39.0°C |
7 (22) |
5 (36) |
2 (11) |
NA |
| Fatigue | 26 (74) | 11 (69) | 15 (79) | 0.700 |
| Myalgia | 19 (54) | 9 (56) | 10 (53) | 1.000 |
| Headache | 12 (34) | 4 (25) | 8 (42) | 0.476 |
| Cough | 7 (20) | 3 (19) | 4 (21) | 1.000 |
| Sputum |
9 (26) |
3 (19) |
6 (32) |
0.460 |
| Lymphadenopathy on physical examination | 5 (14) | 1 (6) | 4 (21) | 0.347 |
| Lymph node enlargement found by CT, n = 32 |
20 (63) |
7 (54) |
13 (68) |
0.473 |
| Gastrointestinal symptoms | ||||
| Overall | 33 (94) | 15 (94) | 18 (95) | 1.000 |
| Anorexia | 21 (60) | 8 (50) | 13 (68) | 0.317 |
| Nausea | 16 (46) | 5 (31) | 11 (58) | 0.176 |
| Abdominal pain | 9 (26) | 6 (38) | 3 (16) | 0.245 |
| Diarrhea | 22 (63) | 12 (75) | 10 (53) | 0.293 |
| Vomiting | 15 (43) | 6 (38) | 9 (47) | 0.734 |
| Diarrhea/vomiting |
26 (74) |
13 (81) |
13 (68) |
0.460 |
| Neurologic symptoms | ||||
| Overall | 27 (77) | 15 (94) | 12 (63) | 0.047 |
| Within 7 d after disease onset | 20 (57) | 14 (88) | 6 (32) | 0.002 |
| Slurred speech | 9 (26) | 7 (44) | 2 (11) | 0.050 |
| Decreased level of consciousness | 26 (74) | 15 (94) | 11 (58) | 0.022 |
| Convulsions |
8 (23) |
6 (38) |
2 (11) |
0.105 |
| Hemorrhagic manifestations | ||||
| Overall | 12 (34) | 8 (50) | 4 (21) | 0.090 |
| Gross hematuria | 2 (6) | 1 (6) | 1 (5) | 1.000 |
| Petechiae | 3 (9) | 1 (6) | 2 (11) | 1.000 |
| Gingival bleeding | 5 (14) | 3 (19) | 2 (11) | 0.642 |
| Hematemesis | 2 (6) | 1 (6) | 1 (5) | 1.000 |
| Hematochezia | 1 (3) | 1 (6) | 0 (0) | 0.457 |
| Melena |
4 (11) |
4 (25) |
0 (0) |
0.035 |
| Treatment | ||||
| Ribavirin | 9 (26) | 6 (38) | 3 (16) | 0.245 |
| IVIG | 7 (20) | 5 (31) | 2 (11) | 0.208 |
| Plasmapheresis | 7 (20) | 4 (25) | 3 (16) | 0.677 |
| CRRT | 10 (29) | 9 (56) | 1 (5) | 0.002 |
*NA, not applicable; CT, computed tomography; IVIG, intravenous immunoglobulin; CRRT, continuous renal replacement therapy.
†Fisher exact test was used to compare groups.
Page created: September 22, 2015
Page updated: September 22, 2015
Page reviewed: September 22, 2015
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.